查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632590

美國PRP 和幹細胞治療脫髮症市場：市場規模、佔有率、趨勢分析（按治療方法、適應症、最終用途和地區）、細分市場預測（2025-2030 年）

U.S. PRP And Stem Cell Alopecia Treatment Market Size, Share & Trends Analysis Report By Treatment (Platelet Rich Plasma Therapy, Stem Cell Therapy), By Indication (Androgenic Alopecia, Alopecia Areata), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國PRP 和幹細胞脫髮症市場的成長和趨勢：

根據 Grand View Research 的新報告，到 2030 年，美國PRP 和幹細胞脫髮症治療市場規模預計將達到 4.3891 億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 9.46%。該市場的成長要素包括疾病意識的提高、治療率的提高以及擴大採用可提供更好患者治療效果的新治療方法。此外，該療法副作用發生率低，預計將推動對富血小板血漿 (PRP) 療法和幹細胞療法的需求。

隨著越來越多的患者青睞新治療方法而非傳統治療方法，預計採用 PRP 和幹細胞療法治療脫髮症的情況將會增加。除此之外，預計預測期內更短的治療時間、更快的毛髮生長和改善的患者預後將推動對這些治療方法的需求。

依治療方法類型分類，2017 年 PRP 手術佔比最大，以手術數量計算為 58.1%。然而，由於 PRP 程序的價格較低，幹細胞治療程序在 2017 年佔據了主要的收益佔有率，價值 7,010 萬美元。根據最終用途，皮膚科診所部門佔 2017 年總市場收益的 85.0%，因為與醫院相比治療成本較低。

競爭環境包括橘郡頭髮修復中心、科羅拉多州毛髮科學中心、Evolution 脫髮研究所、薩沃拉丁美洲容皮膚病學中心、PLC、NovaGenix、維吉尼亞外科中心和邁阿密毛髮移植研究所等診所。

美國PRP 和幹細胞脫髮症治療市場：概述

  • 由於幹細胞療法在治療脫髮和退化性疾病等各種疾病方面具有潛在應用價值，預計預測期內幹細胞療法將以 12.47% 的複合年成長率大幅成長。
  • 男性脫髮症將佔據市場主導地位，到 2024 年將佔據 71.51% 的最大收入佔有率，這是由於其患病率高，影響約 5000 萬男性和 3000 萬女性。
  • 由於皮膚病和男性脫髮症等脫髮症的盛行率不斷上升，皮膚科診所將佔據市場主導地位，到 2024 年將佔據 69.60% 的最大收入佔有率。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第 3美國。

  • 市場概況/相關展望
  • 市場規模和成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 美國PRP 和幹細胞治療脫髮症市場：分析工具
    • 波特五力分析
    • PESTEL 分析

第脫髮症美國。

  • 細分儀表板
  • 美國PRP 和幹細胞脫髮症治療市場：按治療方法進行趨勢分析（2023 年和 2030 年）
  • 富血小板血漿療法
  • 幹細胞治療

第 5 章美國PRP 和幹細胞脫髮症治療市場：按適應症進行的估計和趨勢分析

  • 細分儀表板
  • 美國PRP 和幹細胞治療脫髮症市場：按適應症進行趨勢分析（2023 年和 2030 年）
  • 男性脫髮症
  • 脫髮症
  • 脫髮症
  • 其他

美國6 章。

  • 細分儀表板
  • 美國PRP 和幹細胞治療脫髮症市場：趨勢分析，按最終用途（2023 年和 2030 年）
  • 醫院
  • 皮膚科診所
  • 其他

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司熱圖分析
  • 公司簡介
    • Bauman Medical Group, PA
    • Virginia Surgical Center
    • Nova Medical Hair Transplant
    • Chicago Hair Transplant Clinic
    • Dr. V Medical Aesthetics
    • City Facial Plastics
    • Orange County Hair Restoration
    • MAXIM Hair Restoration
    • New Jersey Hair Restoration Center
    • Hair Restoration Institute of Minnesota
    • Morgenstern Hair Restoration LLC.
Product Code: GVR-2-68038-594-6

U.S. PRP And Stem Cell Alopecia Treatment Market Growth & Trends:

The U.S. PRP and stem cell alopecia treatment market size is anticipated to reach USD 438.91 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.46% from 2025 to 2030. Factors contributing to the growth of this market include rise in disease awareness, increased treatment rate, and growing adoption of novel treatment therapies providing a positive patient outcome. Moreover, lower incidence of negative side effects due to this therapy is anticipated to fuel demand for platelet-rich plasma (PRP) and stem cell therapy.

Adoption of PRP and stem cell therapy for alopecia is expected to increase owing to a rise in the number of patients preferring novel therapies over conventional therapies. In addition to this, shorter treatment duration, faster hair regrowth, and improved patient outcome are expected to drive demand for these therapies over the forecast period.

By treatment type, PRP procedures accounted for the largest share of 58.1% in 2017 in terms of procedural volume. However, owing to lower prices of PRP procedures, stem cell therapy procedures accounted for the dominant revenue share in 2017, valued at USD 70.1 million. By end use, the dermatology clinics segment accounted for 85.0% of the total market revenue in 2017, owing to its lower therapy cost as compared to hospitals.

The competitive landscape includes clinics such as Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, PLC, NovaGenix, Virginia Surgical Center, and Hair Transplant Institute of Miami.

U.S. PRP And Stem Cell Alopecia Treatment Market Report Highlights:

  • Stem cell therapy is expected to grow significantly at a CAGR of 12.47% over the forecast period, owing to its promising applications in treating various conditions, including hair loss and degenerative diseases.
  • Androgenic alopecia dominated the market and accounted for the largest revenue share of 71.51% in 2024 attributed to its high prevalence, affecting approximately 50 million men and 30 million women.
  • Dermatology clinics dominated the market and accounted for the largest revenue share of 69.60% in 2024 driven by the rising prevalence of skin conditions and hair loss disorders, such as androgenic alopecia.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. PRP & Stem Cell Alopecia Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1 Increasing Prevalence of Alopecia
      • 3.3.1.2 Technological Advancements and Research in Regenerative Medicine
      • 3.3.1.3 Increasing Consumer Demand for Non-Invasive and Natural Treatments
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Regulatory and Legal Barriers
      • 3.3.2.2. High Cost of Treatment and Accessibility Issues
      • 3.3.2.3. Lack of Long-Term Clinical Evidence and Efficacy Data
  • 3.4. U.S. PRP & Stem Cell Alopecia Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Platelet Rich Plasma Therapy
    • 4.3.1. Platelet Rich Plasma Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Stem Cell Therapy
    • 4.4.1. Stem Cell Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Androgenic Alopecia
    • 5.3.1. Androgenic Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Alopecia Areata
    • 5.4.1. Alopecia Areata Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cicatricial or Scarring Alopecia
    • 5.5.1. Cicatricial or Scarring Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Dermatology Clinics
    • 6.4.1. Dermatology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Other Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Bauman Medical Group, P.A.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Product Benchmarking
      • 7.4.1.3. Recent Developments/ Strategic Initiatives
    • 7.4.2. Virginia Surgical Center
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Product Benchmarking
      • 7.4.2.3. Recent Developments/ Strategic Initiatives
    • 7.4.3. Nova Medical Hair Transplant
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Product Benchmarking
      • 7.4.3.3. Recent Developments/ Strategic Initiatives
    • 7.4.4. Chicago Hair Transplant Clinic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Recent Developments/ Strategic Initiatives
    • 7.4.5. Dr. V Medical Aesthetics
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Recent Developments/ Strategic Initiatives
    • 7.4.6. City Facial Plastics
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Product Benchmarking
      • 7.4.6.3. Recent Developments/ Strategic Initiatives
    • 7.4.7. Orange County Hair Restoration
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Product Benchmarking
      • 7.4.7.3. Recent Developments/ Strategic Initiatives
    • 7.4.8. MAXIM Hair Restoration
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Recent Developments/ Strategic Initiatives
    • 7.4.9. New Jersey Hair Restoration Center
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Recent Developments/ Strategic Initiatives
    • 7.4.10. Hair Restoration Institute of Minnesota
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Recent Developments/ Strategic Initiatives
    • 7.4.11. Morgenstern Hair Restoration LLC.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Product Benchmarking
      • 7.4.11.3. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. PRP & Stem Cell Alopecia Treatment Market, by Treatment, 2018 - 2030 (USD Million)
  • Table 4 U.S. PRP & Stem Cell Alopecia Treatment Market, by Indication, 2018 - 2030 (USD Million)
  • Table 5 U.S. PRP & Stem Cell Alopecia Treatment Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Key companies undergoing collaboration and partnerships
  • Table 7 Key companies using other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 U.S. PRP & Stem Cell Alopecia Treatment Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Movement Analysis
  • Fig. 16 U.S. PRP & Stem Cell Alopecia Treatment Market: Treatment Outlook and Key Takeaways
  • Fig. 17 PRP Therapy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 18 Stem Cell Therapy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 19 U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Movement Analysis
  • Fig. 20 U.S. PRP & Stem Cell Alopecia Treatment Market: Indication Outlook and Key Takeaways
  • Fig. 21 Androgenic Alopecia Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 22 Alopecia Areata Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 23 Cicatricial Alopecia Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 24 Other Indications Treatment Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Movement Analysis
  • Fig. 26 U.S. PRP & Stem Cell Alopecia Treatment Market: End Use Outlook and Key Takeaways
  • Fig. 27 Dermatology Clinics Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Other End Use Market Estimates and Forecasts, 2018 - 2030
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 U.S. PRP & Stem Cell Alopecia Treatment Market Movement Analysis by Region